Fig. 3From: An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classificationOverall survival depending on the cytogenetic risk group (MRC criteria) in current MDS and AML subtypes. a in the intermediate category (n = 79); b in the unfavorable category (n = 11)Back to article page